The costs and benefits of SGLT2 inhibitors & GLP-1 RAsJuly 15, 2019CardiologyDiabetesNephrologyObesityBusiness of Medicine
BMI screening trigger for type 2 diabetes is unreliable for at-risk black, Hispanic adultsJuly 12, 2019DiabetesObesity
Do black patients with type 2 diabetes gain cardiac benefit from the SGLT2 and GLP-1 drugs?June 25, 2019Diabetes
Drastic weight loss prevents progression to type 2 diabetes, PREVIEW data suggestJune 12, 2019DiabetesObesity
Diabetes, hypertension remission more prevalent in adolescents than adults after gastric bypassMay 22, 2019ObesityCardiologyDiabetes
Type 2 diabetes remission: Reducing excess fat in the liver might be the keyMay 14, 2019DiabetesObesity
